In December 2017 our CEO Paul van den Biggelaar was interviewed by the Life Sciences & Health 010 magazine about thermotherapy and the very…
In February 2018 Sensius was invited for a pitch among other Dutch innovative startups during the congress Innovation for Health, the…
MedValue: "High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer". The prognosis of…
Gerard van Rhoon was honored by receiving the 28th J. Eugene Robinson1 award, which is the most prestigious price of the Annual Congress of…
Sensius, an Erasmus MC Spinoff company developing novel cancer treatment using hyperthermia, is receiving €300,000 from the UNIIQ…
At ESHO2017 in Athens, Sarah Brueningk received the Sensius Young Investigator Award for her presentation “Simulating response to…
Aarau, 1 January 2017 - Swiss health authorities have decided to include treatment of cancer through a combination of radiotherapy and…
Dutch Cancer Foundation (KWF) has collected 18 innovative ideas to keep cancer treatments economically accessible to all patients. This…
Utrecht, 28 November 2016 - STW in the Netherlands has attributed Valerio Fortunati with the title “Simon Stevin Gezel 2016”. He is…
Amersfoort, 27 june 2016 - At a special event of KWF Kankerbestrijding (DCI) on Business Models for the Future, Sensius presented its case…
Rotterdam, 15 september 2015 - At ESHO 2015 in Zurich, Netteke van Holthe shared early experience with the HYPERcollar3D applicator as…
Rotterdam, 10 april 2015 - Erasmus MC Cancer Institute and Sensius BV have signed an agreement to collaborate on the advancement of head…
